Ovid Therapeutics Inc. (OVID) vs Tilray Brands, Inc. (TLRY)
A side-by-side comparison of Ovid Therapeutics Inc. and Tilray Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OVID
Ovid Therapeutics Inc.
$2.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TLRY
Tilray Brands, Inc.
$3.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — OVID vs TLRY
growth of $100 · dividends reinvested · last 8yOVID -77.9% (-17.2%/yr)TLRY -98.3% (-40.1%/yr)OVID compounded faster over this window
Log scale — wide-divergence pair
OVID TLRY
OVID vs TLRY: by the numbers
- •OVID is the larger company ($442M vs $423M market cap).
- •Both run net losses; TLRY's is the smaller (-12.90% vs -2178.90% net margin).
- •TLRY grew revenue faster over the past five years (17.11% vs -62.76% CAGR).
Metrics side by side
Valuation
| Metric | OVID | TLRY |
|---|---|---|
| P/S ratio | 279.43 | 0.37 |
| P/B ratio | 2.11 | 0.26 |
| EV / EBITDA | N/A | 22.89 |
Profitability
| Metric | OVID | TLRY |
|---|---|---|
| Gross margin | 100.00% | 27.57% |
| Operating margin | -585.20% | -5.18% |
| Net margin | -2178.90% | -12.90% |
| ROE | -16.43% | -9.23% |
| ROIC | -26.29% | -2.98% |
Growth (annualized)
| Metric | OVID | TLRY |
|---|---|---|
| Revenue CAGR (5Y) | -62.76% | 17.11% |
| Total return CAGR (5Y) | -6.98% | -49.30% |
Frequently asked
- Which has grown faster, OVID or TLRY?
- Over the past five years, TLRY grew revenue faster — OVID at a -62.76% CAGR versus TLRY at 17.11%.
- How have OVID and TLRY total returns compared?
- Over the past 5 years, OVID delivered -6.98% and TLRY delivered -49.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ovid Therapeutics ROETilray Brands ROEOvid Therapeutics operating marginTilray Brands operating marginOvid Therapeutics revenue growthTilray Brands revenue growthOvid Therapeutics free cash flowTilray Brands free cash flow
Ovid Therapeutics & Tilray Brands appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.